Universal Technical
UTI
$25.50 -2.22%
Exchange: NYSE | Sector: Consumer Defensive | Industry: Education Training Services
Q2 2025
Published: May 8, 2025

Earnings Highlights

  • Revenue of $207.45M up 12.6% year-over-year
  • EPS of $0.21 increased by 50% from previous year
  • Net income of 11.45M
  • "β€œWe now anticipate generating consolidated revenue between $825 million and $835 million, reflecting approximately 13% year-over-year growth. We now expect adjusted EBITDA between $124 million and $128 million, and we now expect new student starts to be between 29,000 and 30,000.”" - Jerome Grant, CEO
UTI
Company UTI

Executive Summary

Universal Technical Institute delivered a robust second quarter for fiscal 2025, underscoring the strength of its two-division model (Concorde and UTI). Revenue rose 12.6% year over year to $207.4 million, led by a 20.3% year-over-year rise in Concorde segment revenue to $73.2 million and an 8.8% rise in the UTI division to $134.2 million. Net income grew 47% year over year to $11.4 million, while adjusted EBITDA advanced roughly 28% to $28.9 million, reflecting disciplined spend and favorable demand dynamics for skilled trades and healthcare programs. Management reaffirmed and elevated full-year guidance, signaling confidence in continued demand momentum and program expansions in the second half of 2025.

UTI’s strategic North Star Phase 2 plan remains a central driver of the growth trajectory. Management outlined a pathway to open at least six new programs annually and at least two new campuses per year beginning in fiscal 2026, with a multi-year roadmap to exceed $1 billion in revenue by 2029 and margins approaching 20% adjusted EBITDA as campuses scale. The near-term cadence includes meaningful investments in marketing, admissions capacity, and campus infrastructure (e.g., HVACR launch at Orlando, EEIT program at Xtend/Mooresville, nursing program expansions, and the Heartland Dental co-branded campus). While these investments compress near-term margins, they are designed to unlock higher, sustainable returns in 2028–2029 and beyond. Investors should monitor enrollment velocity, growth in new programs and capacity, capital expenditures, and the timing of Title IV eligibility for new Concorde campuses.

Key risks to watch include the cost and timing of expansion, regulatory approvals for new campuses, evolving federal higher-education policy, and potential shifts in demand in the macro environment. Nevertheless, the company maintains a constructive outlook, supported by rising demand for skilled trades and healthcare professionals, a favorable macro backdrop for trade schools, and a clear, executable plan to scale the platform.

Key Performance Indicators

Revenue
Increasing
207.45M
QoQ: 2.99% | YoY: 12.64%
Operating Income
Increasing
16.85M
QoQ: -38.67% | YoY: 50.58%
Net Income
Increasing
11.45M
QoQ: -48.33% | YoY: 46.99%
EPS
Increasing
0.21
QoQ: -48.78% | YoY: 50.00%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q2 2025 207.45 0.21 +12.6% View
Q1 2025 201.43 0.40 +15.3% View
Q4 2024 196.36 0.34 +15.3% View
Q3 2024 177.46 0.09 +15.8% View
Q2 2024 184.18 0.14 +12.4% View